8-((4-chlorophenyl)thio)cyclic-3',5'-amp and Diabetes Mellitus

8-((4-chlorophenyl)thio)cyclic-3',5'-amp has been researched along with Diabetes Mellitus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bauer, M; Gertler, FB; Jin, BY; Liao, R; Michel, T; Sartoretto, JL	1

Other Studies

1 other study(ies) available for 8-((4-chlorophenyl)thio)cyclic-3',5'-amp and Diabetes Mellitus

Article	Year
Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart. American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:5 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiomegaly; Cell Adhesion Molecules; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Diabetes Mellitus; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Guanylate Cyclase; Heart Rate; Male; Mice; Mice, Knockout; Microfilament Proteins; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Nucleotides, Cyclic; Phosphoproteins; Phosphorylation; Protein Kinase Inhibitors; Receptors, Adrenergic, beta; Receptors, Cytoplasmic and Nuclear; Serine; Soluble Guanylyl Cyclase; Thionucleotides; Time Factors; Up-Regulation	2009

Article

Year

Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart.

American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:5

Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiomegaly; Cell Adhesion Molecules; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Diabetes Mellitus; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Guanylate Cyclase; Heart Rate; Male; Mice; Mice, Knockout; Microfilament Proteins; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Nucleotides, Cyclic; Phosphoproteins; Phosphorylation; Protein Kinase Inhibitors; Receptors, Adrenergic, beta; Receptors, Cytoplasmic and Nuclear; Serine; Soluble Guanylyl Cyclase; Thionucleotides; Time Factors; Up-Regulation

2009